Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.89.1.421PMID 1370356PMCID PMC48249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

  1994cited by this paper
• Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals.

  1991cited by this paper
• Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.

  1991cited by this paper
• Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-beta 1.

  1991cited by this paper
• Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.

  1991cited by this paper
• CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta.

  1991cited by this paper
• Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.

  1991cited by this paper
• Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.

  1991cited by this paper
• Antigen-driven bystander suppression after oral administration of antigens

  1991cited by this paper
• Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig

  1991cited by this paper
• Antagonistic and agonistic effects of transforming growth factor-beta and IL-1 in rheumatoid synovium.

  1990cited by this paper
• Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia

  1990cited by this paper
• Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action

  1990cited by this paper
• Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.

  1990cited by this paper
• Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.

  1990cited by this paper
• Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.

  1990cited by this paper
• Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha.

  1990cited by this paper
• Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.

  1990cited by this paper
• IL-1 alpha induces expression of active transforming growth factor-beta in nonproliferating T cells via a post-transcriptional mechanism.

  1990cited by this paper
• Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.

  1990cited by this paper
• Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture.

  1989cited by this paper
• Inflammatory and immunomodulatory roles of TGF-beta.

  1989cited by this paper
• Acquisition of immunologic self-tolerance.

  1989cited by this paper
• Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice.

  1989cited by this paper
• Present understanding of suppressor T cells.

  1989cited by this paper
• Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.

  1989cited by this paper
• Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) in complex biological fluids.

  1989cited by this paper
• On the mechanism of human T cell suppression.

  1989cited by this paper
• Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.

  1988cited by this paper
• Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta.

  1988cited by this paper
• Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.

  1988cited by this paper
• Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.

  1987cited by this paper
• Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

  1987cited by this paper
• Lymphokine activation of T4+ T lymphocytes and monocytes.

  1987cited by this paper
• Expression and secretion of type beta transforming growth factor by activated human macrophages.

  1987cited by this paper
• Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

  1987cited by this paper
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

  1986cited by this paper
• Transforming growth factor-beta: biological function and chemical structure.

  1986cited by this paper
• Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.

  1986cited by this paper
• Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.

  1986cited by this paper
• Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity.

  1985cited by this paper
• Suppressor cells and immunoregulation.

  1984cited by this paper
• The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

  1981cited by this paper
• Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin.

  1979cited by this paper
• Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

  1972cited by this paper
• Infectious immunological tolerance.

  1971cited by this paper
• Inhibition of Experimental Drug Allergy by Prior Feeding of the Sensitizing Agent

  1946cited by this paper

• Cytokines Associated with Activation of CD4+CD25+Foxp3+ T Regulatory Cells.

  2026cites this paper
• Undenatured type II collagen for knee osteoarthritis

  2025cites this paper
• Phosphatidylserine exposure on tolerogenic nanoparticle correlate with oral tolerance

  2025cites this paper
• Immune Tolerance Regulation Is Critical to Immune Homeostasis

  2025cites this paper
• Commensal microbiome and gastrointestinal mucosal immunity: Harmony and conflict with our closest neighbor

  2024influential citation
• Therapy with regulatory T-cell infusion in autoimmune diseases and organ transplantation: A review of the strengths and limitations.

  2024cites this paper
• Protecting Allogeneic Pancreatic Islet Grafts by Engineered Veto

  2024cites this paper
• A Perspective on Oral Immunotherapeutic Tools and Strategies for Autoimmune Disorders

  2023cites this paper
• Regulatory T cell and macrophage crosstalk in acute lung injury: future perspectives

  2023cites this paper
• Inhibition of Immunological Suppression.

  2023cites this paper
• Collagen Supplementation for Joint Health: The Link between Composition and Scientific Knowledge

  2023cites this paper
• Oral Tolerance Induced by Heat Shock Protein 65-Producing Lactococcus lactis Mitigates Inflammation in Leishmania braziliensis Infection

  2021cites this paper
• Role of orally induced regulatory T cells in immunotherapy and tolerance.

  2020influential citation
• MuSK EAMG: Immunological Characterization and Suppression by Induction of Oral Tolerance

  2020cites this paper
• Human CD8+CD25 +CD127 low regulatory T cells: microRNA signature and impact on TGF‐β and IL‐10 expression

  2019cites this paper
• Effect of Oral T2 Antigen on Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Mice Model

  2019cites this paper
• [Psycho-immuno-endocrinology of the thyroid gland].

  2018cites this paper
• Immune Tolerance Therapy: A New Method for Treatment of Traumatic Brain Injury

  2018cites this paper
• PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs

  2018cites this paper
• Regulatory T Cells: Their Role, Mechanism of Action, and Impact on Cancer

  2018cites this paper
• History and mechanisms of oral tolerance.

  2017cites this paper
• Is Skin Testing or sIgE Testing Necessary Before Early Introduction of Peanut for Prevention of Peanut Allergy?

  2017cites this paper
• TGF‐β inhibits IL‐7‐induced proliferation in memory but not naive human CD4+ T cells

  2017cites this paper
• Oral tolerance and allergy.

  2017cites this paper
• Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog

  2017cites this paper
• Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice

  2017cites this paper
• The Physiological Induction of Tolerance to Allergens

  2016cites this paper
• Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide

  2016cites this paper
• Changes in Foxp3-Positive Regulatory T Cell Number in the Intestine of Dogs With Idiopathic Inflammatory Bowel Disease and Intestinal Lymphoma

  2016cites this paper
• Pathophysiology of Experimental Autoimmune Encephalomyelitis

  2016cites this paper
• Immune Tolerance for Autoimmune Disease and Cell Transplantation.

  2016cites this paper
• In vivo induction of regulatory T cells for immune tolerance in hemophilia.

  2016cites this paper
• Immunoregulation in celiac disease

  2016cites this paper
• Strategies to circumvent humoral immunity to adeno-associated viral vectors

  2015cites this paper
• Mechanisms of Oral Tolerance.

  2015cites this paper
• Regulatory T cell activity is partly inhibited in a mouse model of chronic Pseudomonas aeruginosa lung infection

  2015cites this paper
• Effector and suppressor T cells in celiac disease.

  2015cites this paper
• Mechanisms of Oral Tolerance to Soluble Protein Antigens

  2015cites this paper
• Regulatory T cells and tolerogenic dendritic cells as critical immune modulators in atherogenesis.

  2015cites this paper
• Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson’s disease

  2015cites this paper
• Animal Models in Biomedical Research

  2015cites this paper
• Crotoxin from Crotalus durissus terrificus Is Able to Down-Modulate the Acute Intestinal Inflammation in Mice

  2015cites this paper
• Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients

  2014cites this paper
• Induction of immune tolerance to caseins and whey proteins by oral intubation in mouse allergy model.

  2014cites this paper
• Estudo da imunomodulação induzida pela crotoxina do veneno de Crotalus durissus terrificus em modelo experimental de doença inflamatória no intestino.

  2014cites this paper
• Single β³-amino acid substitutions to MOG peptides suppress the development of experimental autoimmune encephalomyelitis.

  2014influential citation
• In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance.

  2014cites this paper
• Regulatory T-cell vaccination independent of auto-antigen

  2014cites this paper
• A microRNA profile of human CD8+ regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes

  2014cites this paper
• CD28/CTLA-4/B7 and CD40/CD40L costimulation and activation of regulatory T cells

  2014cites this paper
• Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes‐prone but not in diabetes‐resistant mice

  2013cites this paper
• Can we produce true tolerance in patients with food allergy?

  2013cites this paper
• Regulation of Immunity by Dendritic Cells in the Setting of Liver Transplantation

  2013cites this paper
• Signalling mechanisms underlying priming and tolerance of T cells

  2013cites this paper
• Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells.

  2013cites this paper
• Pillars article: High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 1994. 78: 399-408.

  2013cites this paper
• Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis.

  2013cites this paper
• Oral immunotherapy and tolerance induction in childhood

  2013cites this paper
• Evaluation of the adjuvant effect of Salmonella-based Escherichia coli heat-labile toxin B subunits on the efficacy of a live Salmonella-delivered avian pathogenic Escherichia coli vaccine

  2013cites this paper
• analysis of its mechanism of regulation Identification of a novel natural regulatory CD8 T-cell subset and

  2013cites this paper
• Mechanism of oral tolerance induction to therapeutic proteins.

  2013cites this paper
• Oral tolerance correlates with high levels of lymphocyte activity.

  2012cites this paper
• Regulatory T cells in atherogenesis.

  2012cites this paper
• Conditioning murine B cells for immunoglobulin A production In vitro

  2012cites this paper
• Preoperative mucosal tolerance to brain antigens and a neuroprotective immune response following surgical brain injury.

  2012cites this paper
• An oral CD3-specific antibody suppresses T-cell-induced colitis and alters cytokine responses to T-cell activation in mice.

  2012cites this paper
• Effect of tolerogenic peptide administration on pathogenic antigen-experienced T cells

  2012cites this paper
• Bacillus subtilis

  2012cites this paper
• Mechanisms of allergic sensitization to foods: bypassing immune tolerance pathways.

  2012cites this paper
• The Role of Tumor Suppressors, SHIP and Rb, in Immune Suppressive Cells

  2012cites this paper
• Mechanisms of immune evasion by gliomas.

  2012cites this paper
• Reprogramming the Immune System in IBD

  2012cites this paper
• Allergen-Specific Sublingual Immunotherapy for Respiratory Allergy

  2012cites this paper
• Sensitising capacity of peptides from food allergens

  2012cites this paper
• CD4+CD25+ T regulatory cells do not transfer oral tolerance to peanut allergens in a mouse model of peanut allergy

  2011cites this paper
• Oral tolerance

  2011cites this paper
• CD8+ T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity

  2011cites this paper
• The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel disease.

  2011cites this paper
• Tissue-based class control: the other side of tolerance

  2011cites this paper
• Adaptive T‐cell responses regulating oral tolerance to protein antigen

  2011cites this paper
• Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity

  2011cites this paper
• Strategies of mucosal immunotherapy for allergic diseases

  2011cites this paper
• Effets de différents adjuvants de la famille de la toxine du choléra sur les lymphocytes T CD4 dans un modèle murin d'immunisation intrarectale avec des pseudoparticules virales de rotavirus

  2011cites this paper
• Mucosal tolerance to brain antigens preserves endogenous TGFβ-1 and improves neurological outcomes following experimental craniotomy.

  2011cites this paper
• The Cellular and Molecular Mechanisms of Immuno-Suppression by Human Type 1 Regulatory T Cells

  2011cites this paper
• Nutraceutical efficacy in experimental animal models of inflammatory bowel disease: Echinacea angustifolia, Prunella vulgaris and Hypericum gentianoides

  2011cites this paper
• The Th1 life cycle: molecular control of IFN-γ to IL-10 switching.

  2011cites this paper
• Rapamycin Generates Graft-Homing Murine Suppressor CD8+ T Cells That Confer Donor-Specific Graft Protection

  2011cites this paper
• Oral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecum.

  2011cites this paper
• barrier disease across a major histocompatibility complex-haploidentical Inhibitory effect of a CD4-CDR3 peptide analog on graft-versus-host

  2011cites this paper
• INTRAPERITONEAL ADMINISTRATION OF ADJUVANT

  2011cites this paper
• Role of Cytokines as Mediators and Regulators of Microglial Activity in Inflammatory Demyelination of the CNS

  2010cites this paper
• Invited Review T cell subsets in immunologically-mediated glomerulonephritis

  2010cites this paper
• Suppression of EAE by oral tolerance is independent of endogenous IFN‐β whereas treatment with recombinant IFN‐β ameliorates EAE

  2010cites this paper
• Staphylococcal enterotoxin A: a candidate for the amplification of physiological immunoregulatory responses in the gut

  2010cites this paper
• Monitorización de las células T reguladoras circulantes en trasplante

  2010cites this paper
• Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice.

  2010cites this paper
• Histology and Histopathology In vited Revie w T cell subsets in immunologically-mediated , n , a ' t glomerulonephritis

  2010cites this paper
• Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis.

  2010cites this paper
• Cytokines and Chemokines in Mucosal Homeostasis

  2010cites this paper